At the Capital City Biological Gene Research Institute, Wang Haoyi sat in his laboratory office, looking at news regarding the riedmann virus, his expression occasionally shifting into deep thought.

This human catastrophe had already persisted for several months, and the hardest-hit areas had reached an unimaginably severe state.

Unfortunately, his field of research was the establishment and optimization of gene editing technologies in hematopoietic stem cells and T-cells, studying the characteristics of related gene editing technologies to improve efficiency and specificity, primarily targeting genetic diseases.

This riedmann virus outbreak fell under the category of virology, and since the domestic situation wasn't that severe, they didn't need to get involved.

This virus had already caused panic in the international community, but he was powerless to help.

After finishing the news, Wang Haoyi put down the newspaper and sighed. Worrying about other matters was useless; focusing on his own research was the priority.

Knock knock!!

Just as Wang Haoyi was about to begin his research project, an older man wearing glasses knocked and entered, walking quickly toward him with an air of urgency.

"Director Liu, is there an emergency?"

"Academician Wang, the Dean sent word that there has been a breakthrough in the riedmann virus vaccine at Tangshan. They are currently undergoing an emergency technical assault and need genomics experts."

Hearing this notification, Wang Haoyi stood up abruptly: "I'll go."

Without waiting for Director Liu to speak again, Wang Haoyi began packing his things, preparing to leave the office... East Sea Life Science Research Institute.

Yang Yunjia walked quickly into the laboratory. Inside were members of his team, as well as students and assistants.

His team's key R&D plans were precision medicine research projects, epigenomic detection technology and clinical applications, as well as new RNA methylation epitranscriptomic sequencing technology. Both projects were led by him.

The riedmann virus raging outside belonged to immunology, but since he was not an expert in immunology or virology, he hadn't been summoned by the medical team. He had stayed peacefully at the research institute to continue presiding over their research.

However, just today, a notice came from the Capital City stating that there was progress on the riedmann virus vaccine at Tangshan, and they needed genomics experts to participate in an emergency technical assault.

"Professor Yang, did something happen?" As he stopped in the lab, the other members and students looked at him, and one student asked.

"The Capital City needs gene editing and genomics personnel for an emergency technical assault. Yu Jun, Mi Shuangli, you two come with me."

"Professor Yang, is it convenient to say what technology it is?" asked a female researcher named Mi Shuangli.

"It's at Tangshan Hospital in the Capital City, analyzing the genes of the riedmann virus vaccine."

"Okay."

The two nodded heavily and agreed without hesitation.

The CDC issued a call to action. Genomics and bioinformatics experts and academicians presiding over research projects across the country received the message and agreed without hesitation to head to Tangshan Hospital in the Capital City for the project assault.

In just one day, nearly twenty genomics experts and researchers arrived at Tangshan.

Personnel from the CDC and the Ministry of Health understood the importance of this project. They coordinated centrally, quickly mobilizing experimental equipment and materials to prepare experimental conditions for the researchers.

Tangshan Research Institute.

Chen Mo and Wu Bing, along with their team members, entered the conference room.

Seeing a room full of people, several team members were startled. Some already recognized the faces; including the gene-immunology experts and academicians already on the medical team, there were thirty-three people in the room. It almost included the top tier of domestic genomics experts and academicians, including some of their former mentors.

It could be said that the group of people with the most authority in domestic genomics were all in this conference room.

While they were sizing up the crowd, the experts below were also sizing them up. Seeing Chen Mo and Wu Bing leading the way, followed by a team that was excessively young, many people couldn't help but marvel.

It was this young team that had achieved significant results during two biological terrors, and this time, they had made breakthrough progress even when others were not optimistic. Seeing their own students among the team members, some academicians smiled with satisfaction; at least their students were successful, and they felt very proud.

However, compared to the leader, Chen Mo, it seemed any genius would pale in comparison. Everyone's gaze soon landed on Chen Mo.

In the past, they had only heard his name but never met the man; today, they finally saw him.

Chen Mo was also scanning the experts and researchers in the room.

Their team could have found the toxic proteins themselves, but to speed things up, more hands obviously meant more speed. This time, the CDC and the Ministry of Health coordinated, with support from the two academies, and finding so many researchers exceeded his expectations.

After distributing the materials, Chen Mo walked to the podium of the conference room and went straight to the point.

"This morning, we conducted another blood test on the patient. The results are in your hands. The patient has regained initial consciousness, the antibody concentration in his body has increased compared to two days ago, and the virus count is decreasing. Theoretically, in about five more days, the patient would have formed resistance to the riedmann virus."

Once Chen Mo started speaking, everyone listened intently to his explanation. Many people present were old enough to be the teachers of Chen Mo's teachers, yet the level Chen Mo displayed was enough to be their teacher. The breakthrough in the riedmann virus vaccine was achieved under his direct leadership; no one dared to look down on him because of his age.

Hearing that the vaccine was effective, many showed a hint of joy, but their pleasant surprise was immediately interrupted by Chen Mo.

"But we detected two types of toxic proteins in the patient's body. These two toxic proteins increased as the antibody concentration rose. Just two hours ago, the patient died in agony, unable to wait for five days. He was not killed by the riedmann virus, but by the toxic proteins in his body."

"Our preliminary judgment is that these toxic proteins are caused by potential toxic protein genes present in the vaccine platform system's mRNA. Therefore, your next task is to find these two toxic protein genes in the vaccine. We will find a way to knock out these two gene segments to eliminate the vaccine's toxicity."

"Academician Chen, is there any drug that can degrade these two toxic proteins to achieve a therapeutic effect?"

Hearing the interruption from below, Chen Mo nodded and replied: "We have considered this method. The medical team is looking for drugs to degrade the toxic proteins, but none have been found yet. Furthermore, that would only treat the symptoms and not the root cause."

"Academician Chen, are there samples of the toxic proteins?" Yang Yunjia, sitting in the first row, spoke up to ask.

"Yes, we isolated some samples from the patient's blood, but not many. Once the project begins, samples of the toxic proteins will be distributed to each laboratory. Next, I will explain the relevant characteristics of the toxic proteins and the data related to the mRNA. If you have any questions, you can interrupt and ask me or Academician Wu. Within the limits of what is permitted, we will do our best to answer you."

With the explanation finished, Chen Mo began to describe some characteristics of the toxic proteins and the data related to the mRNA to facilitate their research.